19.900USD+19.900After-hours 07/30, 20:00 (ET)
2.04BMarket Cap
LossP/E TTM
Viridian Therapeutics Inc
VRDN Financials
See Viridian Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Viridian Therapeutics Inc Earnings Date
Latest Release
May 5, 2026
EPS / Forecast
-1.03/-1.09
Revenue / Forecast
141.00K/27.50K
Revenue(YoY)
70.85M
23359.93%
Analyst Rating
BUY
2026/07/30
FAQs
What is the total revenue of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its total revenue reached 70.85M, with a year-on-year change of 302.00K.
What are the current assets of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its current assets were 894.23M, with a year-on-year change of 21.09.
What are the total assets of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its total assets of Viridian Therapeutics Inc were 899.42M, with a year-on-year change of 21.15.
What are the total liabilities of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its total liabilities of Viridian Therapeutics Inc were 177.25M, with a year-on-year change of 150.48.
What is the total equity of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its total equity of Viridian Therapeutics Inc was 722.17M, with a year-on-year change of 7.52.
What is the net operating income of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its net operating income of Viridian Therapeutics Inc was -324.92M, with a year-on-year change of -8.66.
What is the net investment of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its net investment of Viridian Therapeutics Inc was -37.56M, with a year-on-year change of 83.57.
What is the net financing of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its net financing of Viridian Therapeutics Inc was 426.74M, with a year-on-year change of -6.77.
What is the Earnings Per Share (EPS) of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -4.04, with a year-on-year change of -1.60.
What is the net income of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its net income was -342.60M, with a year-on-year change of -26.91.
What is the net margin of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its net profit margin was -483.57, with a year-on-year change of 99.46.
What is the debt-to-asset ratio of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 9.36, with a year-on-year change of 237.61.
What is the Return on Equity (ROE) of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -63.87, with a year-on-year change of 15.03.
What is the Return on Assets (ROA) of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -41.73, with a year-on-year change of 4.70.
What is the operating profit of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its operating profit was -324.92M, with a year-on-year change of -8.66.